Uncategorized
VIDEO: Following FDA approval, Avedro set to enter market
NEW ORLEANS —At the American Society of Cataract and Refractive Surgery meeting, Rajesh K. Rajpal, MD, chief medical officer of Avedro, discusses the recent approval of the company’s cross-linking system indication for treating keratoconus and the planned timeline to bring the technology to doctors’ offices in the U.S.